Acinetobacter baumannii has emerged as a highly troublesome pathogen for many
institutions globally. As a consequence of its immense ability to acquire or upregulate …

The medical community relies on clinical expertise and published guidelines to assist
physicians with choices in empirical therapy for system-based infectious syndromes, such as …

Pseudomonas aeruginosa is an important bacterial pathogen, particularly as a cause of
infections in hospitalised patients, immunocompromised hosts and patients with cystic …

The increasing trend of carbapenem resistance in Acinetobacter baumannii worldwide is a
concern since it limits drastically the range of therapeutic alternatives. Metallo-β-lactamases …

Acinetobacter species and Pseudomonas aeruginosa are noted for their intrinsic resistance
to antibiotics and for their ability to acquire genes encoding resistance determinants …

Institutional outbreaks caused by Acinetobacter baumannii strains that have acquired
multiple mechanisms of antimicrobial drug resistance constitute a growing public-health …

Since 2000, Escherichia coli producing CTX-M enzymes (especially CTX-M-15) have
emerged worldwide as important causes of community-onset urinary tract infections (UTIs) …

Background Due to scarce therapeutic options, hospital-acquired infections caused by
Klebsiella pneumoniae (KP), particularly carbapenem-resistant KP (CRKP), pose enormous …

Aims: Carbapenem-resistant Klebsiella pneumoniae (CRKP) infection has been rapidly
emerging as a life-threatening nosocomial disease in many countries. However, studies on …

Isolates of Pseudomonas aeruginosa or Acinetobacter species that are resistant to all, or
almost all, commercially available antibiotics are now prevalent worldwide. Typically, these …